| Literature DB >> 27357673 |
Giulio Caravagna1, Alex Graudenzi2, Daniele Ramazzotti3, Rebeca Sanz-Pamplona4, Luca De Sano3, Giancarlo Mauri5, Victor Moreno6, Marco Antoniotti7, Bud Mishra8.
Abstract
The genomic evolution inherent to cancer relates directly to a renewed focus on the voluminous next-generation sequencing data and machine learning for the inference of explanatory models of how the (epi)genomic events are choreographed in cancer initiation and development. However, despite the increasing availability of multiple additional -omics data, this quest has been frustrated by various theoretical and technical hurdles, mostly stemming from the dramatic heterogeneity of the disease. In this paper, we build on our recent work on the "selective advantage" relation among driver mutations in cancer progression and investigate its applicability to the modeling problem at the population level. Here, we introduce PiCnIc (Pipeline for Cancer Inference), a versatile, modular, and customizable pipeline to extract ensemble-level progression models from cross-sectional sequenced cancer genomes. The pipeline has many translational implications because it combines state-of-the-art techniques for sample stratification, driver selection, identification of fitness-equivalent exclusive alterations, and progression model inference. We demonstrate PiCnIc's ability to reproduce much of the current knowledge on colorectal cancer progression as well as to suggest novel experimentally verifiable hypotheses.Entities:
Keywords: Bayesian structural inference; cancer evolution; causality; next generation sequencing; selective advantage
Mesh:
Year: 2016 PMID: 27357673 PMCID: PMC4948322 DOI: 10.1073/pnas.1520213113
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205